Skip to Main Content

Paper Details

Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.
Pediatric Blood and Cancer
4
2021
4-hydroxycyclophosphamide, 4HCY, Patients, RMS, SNPs, actinomycin, cyclophosphamide, cyclophosphamide pharmacokinetic candidate genes, genes, irinotecan, patients, rhabdomyosarcoma, rhabdomyosarcoma (RMS, rhabdomyosarcoma (RMS) cells, single-nucleotide polymorphisms, vincristine
Author NameAffiliation
Douglas S HawkinsSeattle Children's Hospital
Douglas S HawkinsUniversity of Washington
  • 1 - 2

Datasets

Release 1.2